More recently, a pooled analysis of all published case-control studies until 2006 [7], and the combination of this meta-analysis with at least one subsequent study [8] supported the notion of a significant negative association of the CCR5 d32 deletion with RA. The gene discussed is CCR5; the disease is rheumatoid arthritis.